Globally, there are about 350 million people, or 8% of the population, with a rare disease, yet only 5% of these diseases have an approved therapy. It’s a dilemma that is historically overlooked, largely because it’s hard to make a profit from a treatment that affects so few people. How do we empower patients with rare diseases when a lack of treatment options and awareness can result in significant health complications? [...]